Grants per year
Personal profile
Research Interests
I have an interest in the development of clinical trials, as well as studying novel biomarkers that may be used as prognostic and predictive tools in the management of melanoma and other advanced skin cancers, as well as cancer of unknown primary.
Training Experience
| 2011 | Residency, Case Western Reserve University Hospital |
| 2014 | Fellowship, New York University Medical Center |
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Education/Academic qualification
MD, Michigan State University
… → 2008
MS, Michigan State University
… → 2003
Research interests
- Cancer of Unknown Primary
- Clinical Research
- Drug Discovery
- Melanoma
- Skin Cancer
Fingerprint
Dive into the research topics where Sunandana Chandra is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Prot #C4471001: A Two-Part, Phase 1A/B, Open-Label, Multicenter Trial Evaluating Pharmacokinetics, Safety and Efficacy of PF-07284890 (ARRY-461) in Participants with BRAF V600-Mutant Solid Tumors with and without Brain Involvement
PPD Investigator Services, LLC, Pfizer Inc.
10/14/21 → 10/14/24
Project: Research project
-
Prot #OMS-I103: The PISCES Study: A Multicenter Phase 2, Open-Label Study of Intratumoral Tavokinogene Telseplasmid (tavo, pIL-12) plus Electroporation in Combination with Intravenous Pembrolizumab in Patients with Stage III/IV Melanoma who are Progressin
Precision Oncology, LLC, OncoSec Medical Incorporated
7/1/20 → 7/1/23
Project: Research project
-
BAMM (BRAF Autophagy and MEK Inhibition in Melanoma): A Phase I/II Trial of Dabrafenib, Trametinib, and Hydroxychloroquine in Advanced BRAFV600-mutant Melanoma
Mehnert, J. M., Mitchell, T. C., Huang, A. C., Aleman, T. S., Kim, B. J., Schuchter, L. M., Linette, G. P., Karakousis, G. C., Mitnick, S., Giles, L., Carberry, M., Frey, N., Kossenkov, A., Groisberg, R., Hernandez-Aya, L. F., Ansstas, G., Silk, A. W., Chandra, S., Sosman, J. A., Gimotty, P. A., & 2 others, Mar 15 2022, In: Clinical Cancer Research. 28, 6, p. 1098-1106 9 p.Research output: Contribution to journal › Article › peer-review
Open Access6 Scopus citations -
Clinical activity of PD-1 inhibition in the treatment of locally advanced or metastatic basal cell carcinoma
In, G. K., Nallagangula, A., Choi, J. S., Tachiki, L., Blackburn, M. J., Capone, S., Bollin, K. B., Reuben, D. Y., Shirai, K., Zhang-Nunes, S., Ragab, O., Terando, A., Hu, J. C., Lee, H., Bhatia, S., Chandra, S., Lutzky, J. & Gibney, G. T., May 1 2022, In: Journal for immunotherapy of cancer. 10, 5Research output: Contribution to journal › Article › peer-review
Open Access -
Evidence-Based Clinical Practice Guidelines for Extramammary Paget Disease
Kibbi, N., Owen, J. L., Worley, B., Wang, J. X., Harikumar, V., Downing, M. B., Aasi, S. Z., Aung, P. P., Barker, C. A., Bolotin, D., Bordeaux, J. S., Cartee, T. V., Chandra, S., Cho, N. L., Choi, J. N., Chung, K. Y., Cliby, W. A., Dorigo, O., Eisen, D. B., Fujisawa, Y., & 32 others, Apr 2022, In: JAMA Oncology. 8, 4, p. 618-628 11 p.Research output: Contribution to journal › Review article › peer-review
7 Scopus citations -
Leptomeningeal metastases: the future is now
Lukas, R. V., Thakkar, J. P., Cristofanilli, M., Chandra, S., Sosman, J. A., Patel, J. D., Kumthekar, P., Stupp, R. & Lesniak, M. S., Feb 2022, In: Journal of Neuro-Oncology. 156, 3, p. 443-452 10 p.Research output: Contribution to journal › Review article › peer-review
-
Acute kidney injury in patients treated with immune checkpoint inhibitors
Gupta, S., Short, S. A. P., Sise, M. E., Prosek, J. M., Madhavan, S. M., Soler, M. J., Ostermann, M., Herrmann, S. M., Abudayyeh, A., Anand, S., Glezerman, I., Motwani, S. S., Murakami, N., Wanchoo, R., Ortiz-Melo, D. I., Rashidi, A., Sprangers, B., Aggarwal, V., Malik, A. B., Loew, S., & 43 others, Oct 8 2021, In: Journal for immunotherapy of cancer. 9, 10, e003467.Research output: Contribution to journal › Article › peer-review
Open Access19 Scopus citations